119 related articles for article (PubMed ID: 36287068)
1. Modeling time-varying recruitment rates in multicenter clinical trials.
Perperoglou A; Zhang Y; Kipourou DK
Biom J; 2023 Aug; 65(6):e2100377. PubMed ID: 36287068
[TBL] [Abstract][Full Text] [Related]
2. Interim recruitment prediction for multi-center clinical trials.
Urbas S; Sherlock C; Metcalfe P
Biostatistics; 2022 Apr; 23(2):485-506. PubMed ID: 32978616
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Clinical Trial Educator program - a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial.
Kendall B; Städeli R; Schegg B; Olbrich M; Chen E; Harmelin-Kadouri R; Aurup P; Schwab T; Hildemann SK
Clin Trials; 2012 Jun; 9(3):358-66. PubMed ID: 22426648
[TBL] [Abstract][Full Text] [Related]
5. Using Poisson-gamma model to evaluate the duration of recruitment process when historical trials are available.
Minois N; Lauwers-Cances V; Savy S; Attal M; Andrieu S; Anisimov V; Savy N
Stat Med; 2017 Oct; 36(23):3605-3620. PubMed ID: 28608361
[TBL] [Abstract][Full Text] [Related]
6. Predictive event modelling in multicenter clinical trials with waiting time to response.
Anisimov VV
Pharm Stat; 2011; 10(6):517-22. PubMed ID: 22140055
[TBL] [Abstract][Full Text] [Related]
7. A time-dependent Poisson-Gamma model for recruitment forecasting in multicenter studies.
Turchetta A; Savy N; Stephens DA; Moodie EEM; Klein MB
Stat Med; 2023 Oct; 42(23):4193-4206. PubMed ID: 37491664
[TBL] [Abstract][Full Text] [Related]
8. The time-dependent Poisson-gamma model in practice: Recruitment forecasting in HIV trials.
Turchetta A; Moodie EEM; Stephens DA; Savy N; Moodie Z
Contemp Clin Trials; 2024 Jun; ():107607. PubMed ID: 38908745
[TBL] [Abstract][Full Text] [Related]
9. Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study.
Campbell MK; Snowdon C; Francis D; Elbourne D; McDonald AM; Knight R; Entwistle V; Garcia J; Roberts I; Grant A; Grant A;
Health Technol Assess; 2007 Nov; 11(48):iii, ix-105. PubMed ID: 17999843
[TBL] [Abstract][Full Text] [Related]
10. The "constant intake rate" assumption in interim recruitment goal methodology for multicenter clinical trials.
Williford WO; Bingham SF; Weiss DG; Collins JF; Rains KT; Krol WF
J Chronic Dis; 1987; 40(4):297-307. PubMed ID: 3558706
[TBL] [Abstract][Full Text] [Related]
11. Estimating Site Performance (ESP): can trial managers predict recruitment success at trial sites? An exploratory study.
Bruhn H; Treweek S; Duncan A; Shearer K; Cameron S; Campbell K; Innes K; McRae D; Cotton SC
Trials; 2019 Apr; 20(1):192. PubMed ID: 30944022
[TBL] [Abstract][Full Text] [Related]
12. Bayesian accrual modeling and prediction in multicenter clinical trials with varying center activation times.
Liu J; Wick J; Jiang Y; Mayo M; Gajewski B
Pharm Stat; 2020 Sep; 19(5):692-709. PubMed ID: 32319194
[TBL] [Abstract][Full Text] [Related]
13. Statistical modeling and prediction of clinical trial recruitment.
Lan Y; Tang G; Heitjan DF
Stat Med; 2019 Mar; 38(6):945-955. PubMed ID: 30411375
[TBL] [Abstract][Full Text] [Related]
14. Bayesian modeling and prediction of accrual in multi-regional clinical trials.
Deng Y; Zhang X; Long Q
Stat Methods Med Res; 2017 Apr; 26(2):752-765. PubMed ID: 25367100
[TBL] [Abstract][Full Text] [Related]
15. Models for patients' recruitment in clinical trials and sensitivity analysis.
Mijoule G; Savy S; Savy N
Stat Med; 2012 Jul; 31(16):1655-74. PubMed ID: 22344741
[TBL] [Abstract][Full Text] [Related]
16. Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study.
Menon U; Gentry-Maharaj A; Ryan A; Sharma A; Burnell M; Hallett R; Lewis S; Lopez A; Godfrey K; Oram D; Herod J; Williamson K; Seif M; Scott I; Mould T; Woolas R; Murdoch J; Dobbs S; Amso N; Leeson S; Cruickshank D; McGuire A; Campbell S; Fallowfield L; Skates S; Parmar M; Jacobs I
BMJ; 2008 Nov; 337():a2079. PubMed ID: 19008269
[TBL] [Abstract][Full Text] [Related]
17. Maximizing Patient Recruitment and Retention in a Secondary Stroke Prevention Clinical Trial: Lessons Learned from the STAND FIRM Study.
Thayabaranathan T; Cadilhac DA; Srikanth VK; Fitzgerald SM; Evans RG; Kim J; Gerraty RP; Phan TG; Bladin CF; Nelson MR; Frayne JH; Thrift AG
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1371-80. PubMed ID: 27009610
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of models to predict recruitment to multicentre clinical trials.
Barnard KD; Dent L; Cook A
BMC Med Res Methodol; 2010 Jul; 10():63. PubMed ID: 20604946
[TBL] [Abstract][Full Text] [Related]
19. Modelling, prediction and adaptive adjustment of recruitment in multicentre trials.
Anisimov VV; Fedorov VV
Stat Med; 2007 Nov; 26(27):4958-75. PubMed ID: 17639505
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
